Asthma is a chronic inflammatory disease of the lungs where the airways become so obstructed the sufferer struggles to breathe. It's vastly more prevalent in Western societies, and usually develops in childhood. But what ...
Aug 24, 2018
0
1
(Medical Xpress)—A collaboration among researchers in Israel and the United States has resulted in the discovery of a new pathway that has broad implications for treating allergic diseases – particularly eosinophil-associated ...
Nov 11, 2013
0
0
A new study implicates remodeling of nerves in the airways as a key contributor to heightened sensitivity and airway constriction in patients with asthma.
Sep 5, 2018
0
40
Immune cells which are reduced in number by obesity could be a new target to treat diseases such as type 2 diabetes and hypertension that affect overweight people, according to a collaborative study between The University ...
Mar 17, 2017
1
88
Our researchers have revealed the identities of new subsets of immune cells at the frontline of our body's defenses against infection.
Aug 7, 2018
0
6
Inspired by kirigami, the Japanese art of folding and cutting paper to create three-dimensional structures, MIT engineers and their collaborators have designed a new type of stent that could be used to deliver drugs to the ...
Jun 14, 2021
0
13
(HealthDay)—For children with eosinophilic esophagitis (EoE), eight weeks of a four-food elimination diet can induce remission, according to a study published online June 8 in Clinical Gastroenterology and Hepatology.
Jul 7, 2017
0
1
The largest study of patients with severe asthma to date, published in the Lancet special issue on respiratory medicine, shows that those treated with the monoclonal antibody mepolizumab experienced an almost 50 percent reduction ...
Aug 16, 2012
0
0
A new study from Ann & Robert H. Lurie Children's Hospital of Chicago determined the threshold for a new measure of early scarring in the esophagus of children with eosinophilic esophagitis (EoE), which allows immediate intervention ...
Sep 16, 2022
0
34
A National Institutes of Health clinical trial has found that a monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have a form of severe asthma, are prone ...
Aug 10, 2022
0
37
